Submitted:
09 October 2024
Posted:
10 October 2024
Withdrawn:
17 January 2025
This preprint has been withdrawn
Preprint
Review
This version is not peer-reviewed.
Withdrawn:
Real-World Evidence Evaluating Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Systematic Literature Review
MDPI Initiatives
Important Links
© 2025 MDPI (Basel, Switzerland) unless otherwise stated